Momentum of Drug Price Transparency Bills Growing
There are now 15 states that have filed bills related to improving transparency around drug prices this year. The Hill reported that states are pursuing this legislation as an alternative to price-limiting bills for the purpose of addressing rising drug costs. Predictably, drug lobbyists are pushing back, explaining that disclosing costs doesn’t fully show the cost of drug development. The industry has torpedoed other bills aimed at curbing costs, such as California’s initiative to restrict what the state pays for drugs.
Massachusetts Vows to Protect Planned Parenthood
There is a real threat that Congress could block funding to Planned Parenthood, so it may be up to states to keep the organization funded. In Massachusetts, the governor has vowed to “plug any holes in the budget” for the state’s Planned Parenthood, according to Reuters. Close to 10% of the state’s Planned Parenthood budget comes from Medicaid reimbursements that cover services, such as screening and treatment for cancers and sexually transmitted diseases, for roughly one-third of its total patients.
Utah Embraces the ACA After Trying to Squash It
A phenomenon occurring in Utah may highlight the difficulty of repealing the Affordable Care Act (ACA). The traditionally red state has seen a surge of support for the health law, and they don’t want their representatives to vote for repealing Obamacare, reported The New York Times. With a recent increase of residents signing up for coverage, even Republicans are starting to support the law. The situation in Utah outlines the difficult situation Republicans in Congress are in as their part begins the work of repealing and replacing the health law. As with other states, Congressional offices in Utah are being flooded with messages from concerned residents who don’t want to lose their health insurance.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More